These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26384490)

  • 1. Impact on Drug Safety of Variation in Adherence: The Need for Routinely Reporting Measures of Dose Intensity in Medication Safety Studies Using Electronic Health Data.
    Roughead EE; Pratt NL
    Drug Saf; 2015 Dec; 38(12):1145-52. PubMed ID: 26384490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-level variation in and practices associated with dabigatran adherence.
    Shore S; Ho PM; Lambert-Kerzner A; Glorioso TJ; Carey EP; Cunningham F; Longo L; Jackevicius C; Rose A; Turakhia MP
    JAMA; 2015 Apr; 313(14):1443-50. PubMed ID: 25871670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A primary care, electronic health record-based strategy to promote safe drug use: study protocol for a randomized controlled trial.
    Przytula K; Bailey SC; Galanter WL; Lambert BL; Shrestha N; Dickens C; Falck S; Wolf MS
    Trials; 2015 Jan; 16():17. PubMed ID: 25622970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.
    Lorimer S; Cox A; Langford NJ
    J Clin Pharm Ther; 2012 Apr; 37(2):148-52. PubMed ID: 21592157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
    Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
    Trials; 2015 Jan; 16():2. PubMed ID: 25572800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
    Glund S; Stangier J; Schmohl M; Gansser D; Norris S; van Ryn J; Lang B; Ramael S; Moschetti V; Gruenenfelder F; Reilly P; Kreuzer J
    Lancet; 2015 Aug; 386(9994):680-90. PubMed ID: 26088268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international comparison of spontaneous adverse event reports and potentially inappropriate medicine use associated with dabigatran.
    McDonald CJ; Kalisch Ellett LM; Barratt JD; Caughey GE
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):399-405. PubMed ID: 24841749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to anticoagulant treatment with dabigatran in a real-world setting.
    Schulman S; Shortt B; Robinson M; Eikelboom JW
    J Thromb Haemost; 2013 Jul; 11(7):1295-9. PubMed ID: 23855420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial.
    Bender BG; Cvietusa PJ; Goodrich GK; Lowe R; Nuanes HA; Rand C; Shetterly S; Tacinas C; Vollmer WM; Wagner N; Wamboldt FS; Xu S; Magid DJ
    JAMA Pediatr; 2015 Apr; 169(4):317-23. PubMed ID: 25664620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study.
    Hedna K; Hägg S; Andersson Sundell K; Petzold M; Hakkarainen KM
    Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1317-25. PubMed ID: 24127242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.
    Hsu KL; Fink JC; Ginsberg JS; Yoffe M; Zhan M; Fink W; Woods CM; Diamantidis CJ
    Am J Kidney Dis; 2015 Oct; 66(4):621-9. PubMed ID: 25979348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polypill strategy to improve adherence: results from the FOCUS project.
    Castellano JM; Sanz G; Peñalvo JL; Bansilal S; Fernández-Ortiz A; Alvarez L; Guzmán L; Linares JC; García F; D'Aniello F; Arnáiz JA; Varea S; Martínez F; Lorenzatti A; Imaz I; Sánchez-Gómez LM; Roncaglioni MC; Baviera M; Smith SC; Taubert K; Pocock S; Brotons C; Farkouh ME; Fuster V
    J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2071-82. PubMed ID: 25193393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial.
    Kamal AK; Muqeet A; Farhat K; Khalid W; Jamil A; Gowani A; Muhammad AA; Zaidi F; Khan D; Elahi T; Sharif S; Raz S; Zafar T; Bokhari SS; Rahman N; Sultan FA; Sayani S; Virani SS
    Trials; 2016 Mar; 17(1):121. PubMed ID: 26944938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cosmetovigilance survey in Europe.
    Sautebin L
    Pharmacol Res; 2007 May; 55(5):455-60. PubMed ID: 17368906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment.
    Hammad TA; Neyarapally GA; Pinheiro SP; Iyasu S; Rochester G; Dal Pan G
    Clin Trials; 2013; 10(3):389-97. PubMed ID: 23508987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of different patient safety reporting systems: much ado about nothing?].
    Dolores Menéndez M; Rancaño I; García V; Vallina C; Herranz V; Vázquez F
    Rev Calid Asist; 2010; 25(4):232-6. PubMed ID: 20494603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Qi-Wei-Qing-Yan aerosol in treatment of acute pharyngitis (lung-stomach excess-heat syndrome): study protocol for a randomized controlled trial.
    Jiang HL; She B; Liu W; Mao B; Zhang JY
    Trials; 2016 Feb; 17():99. PubMed ID: 26896352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.